Analyzing Quorum Health (QHC) & Its Peers

Quorum Health (NYSE: QHC) is one of 15 public companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it weigh in compared to its rivals? We will compare Quorum Health to similar businesses based on the strength of its profitability, institutional ownership, dividends, valuation, earnings, analyst recommendations and risk.

Institutional & Insider Ownership

81.5% of Quorum Health shares are owned by institutional investors. Comparatively, 69.5% of shares of all “Hospitals, Clinics & Primary Care Services” companies are owned by institutional investors. 4.7% of Quorum Health shares are owned by insiders. Comparatively, 10.8% of shares of all “Hospitals, Clinics & Primary Care Services” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Quorum Health and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Quorum Health -5.72% -86.78% -5.83%
Quorum Health Competitors 4.79% -0.12% 4.50%

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Quorum Health and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quorum Health 1 3 0 0 1.75
Quorum Health Competitors 57 326 509 9 2.52

Quorum Health presently has a consensus target price of $3.88, suggesting a potential downside of 15.76%. As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 25.64%. Given Quorum Health’s rivals stronger consensus rating and higher possible upside, analysts plainly believe Quorum Health has less favorable growth aspects than its rivals.

Valuation & Earnings

This table compares Quorum Health and its rivals gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Quorum Health $2.42 billion -$347.68 million -0.73
Quorum Health Competitors $1.06 billion -$22.56 million 671.43

Quorum Health has higher revenue, but lower earnings than its rivals. Quorum Health is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Volatility and Risk

Quorum Health has a beta of 7.76, indicating that its share price is 676% more volatile than the S&P 500. Comparatively, Quorum Health’s rivals have a beta of 1.43, indicating that their average share price is 43% more volatile than the S&P 500.

Summary

Quorum Health rivals beat Quorum Health on 9 of the 12 factors compared.

About Quorum Health

Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR). It operates QHR, which is a hospital management advisory and consulting services that provides services to non-affiliated general acute care hospitals. Its hospitals and its affiliated businesses offer services, such as general acute care, emergency room, general and specialty surgery and rehabilitation services.

Receive News & Ratings for Quorum Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply